T38.7X2A Poisoning by androgens and anabolic congeners, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by androgens and anabolic congeners, intentional self-harm, initial encounter

Summary

This condition describes intentional self-harm resulting from poisoning by androgens or anabolic congeners during an initial encounter. Androgens and anabolic agents are used for therapeutic purposes, such as hormone replacement or anabolic effects, and intentional exposure can lead to harmful outcomes. The code applies to self-harm scenarios, distinguishing them from accidental or therapeutic adverse effects.

Causes

Intentional self-harm may result from deliberate ingestion or exposure to androgens or anabolic agents. These substances are often used therapeutically or misused, and self-harm can occur through intentional overdose or misuse. Underlying factors like mental health conditions or substance use disorders may contribute to such incidents.

Risk Factors

• Use of androgen or anabolic therapies for medical conditions
• Polypharmacy involving hormonal agents
• Incorrect dosing or administration
• Individual sensitivity to androgenic substances
• Renal or hepatic impairment affecting drug metabolism
• History of self-harm or mental health disorders

Symptoms

Symptoms vary based on the specific agent and exposure level. Poisoning may cause virilization (e.g., hirsutism, voice deepening), electrolyte imbalances, or cardiovascular effects. Other manifestations can include hepatotoxicity, mood changes, or metabolic disturbances.

Diagnosis

Diagnosis involves clinical evaluation, including history of exposure, physical examination, and laboratory tests to assess organ function and substance levels. Toxicology screening may be used to confirm exposure. Documentation of intent (intentional self-harm) and encounter type (initial) is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying intent. This may include supportive care, antidotes (if available), and psychiatric evaluation. Long-term management may involve mental health support and substance use counseling.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning and timely intervention. Follow-up includes monitoring for complications, reassessment of mental health, and ongoing care to prevent recurrence. Regular check-ins with healthcare providers are essential for recovery.

Complications

Complications can include organ damage (e.g., liver or kidney injury), cardiovascular issues, or psychological effects. Severe cases may lead to long-term disability or mortality if not addressed promptly.

Lifestyle & Prevention

Prevention involves proper storage and disposal of medications, education on safe use, and addressing underlying mental health concerns. Avoiding misuse of androgens or anabolic agents and seeking help for substance use disorders can reduce risk.

When to Seek Professional Help

Seek immediate medical attention if intentional exposure to androgens or anabolic agents occurs. Signs of poisoning, such as severe symptoms or altered mental status, require urgent care. Mental health support should be sought for ongoing concerns.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (initial) clearly. Ensure the code aligns with clinical documentation, including details of exposure and treatment. Verify that the code is used for the initial encounter and not subsequent care.